User menu

Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. : The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

Bibliographic reference Schöffski, Patrick ; Blay, J.-Y. ; De Greve, J. ; Brain, E. ; Machiels, Jean-Pascal ; et. al. Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. : The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI).15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin(Germany), du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 2, p. 138-139 (2009)
Permanent URL http://hdl.handle.net/2078.1/58661